05-Nov-2026 11:22:11

HESTERBIOGeneral news

HESTERBIO Q2 FY27; CONS NET PROFIT UP 40.94% AT ₹20.36 CR (YOY), DOWN 79.00% (QOQ)

REVENUE UP 37.96% AT ₹97.91 CR (YOY), UP 26.76% (QOQ) EBITDA UP 178.73% AT ₹32.66 CR (YOY), UP 43.39% (QOQ) MARGINS AT 33.36% VS 16.51% (YOY), 29.49% (QOQ)

Hester Biosciences Ltd

Open attachment

← Back to feed